Jun 14, 2024 06:00AM
May 14, 2024 04:01PM
Apr 23, 2024 06:00AM
Feb 26, 2024 05:49AM
Oct 20, 2023 06:01AM
Oct 20, 2023 06:00AM
May 30, 2023 07:04AM BeiGene' (BGNE) BRUKINSA Approved in Canada for the Treatment of Chronic Lymphocytic Leukemia
May 30, 2023 07:00AM
May 8, 2023 05:27AM
May 6, 2023 08:00AM
Jan 19, 2023 05:03PM
Jan 19, 2023 07:00AM
Nov 22, 2022 08:30AM
Nov 17, 2022 07:00AM BeiGene (BGNE) Announces EU Approval of BRUKINSA for Treatment of Adults with CLL
Nov 17, 2022 07:00AM
Oct 14, 2022 06:30AM
Oct 14, 2022 06:30AM
Jun 10, 2022 07:02AM
Jun 10, 2022 07:00AM
Dec 10, 2021 06:15AM
Dec 10, 2021 03:00AM BeiGene Presents Results from Phase 3 Trial of Tislelizumab in Nasopharyngeal Cancer at ESMO Immuno-Oncology Congress 2021
Aug 23, 2021 05:31AM
Aug 22, 2021 07:00PM
Jul 9, 2021 06:20AM
Jul 9, 2021 12:00AM
Jun 23, 2021 06:18AM
Jun 23, 2021 12:00AM
Nov 17, 2016 09:06AM Form S-1/A BeiGene, Ltd.
Nov 10, 2016 09:21AM

64,524 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All